Fire Fight: Smother the Flame of Type 2 Inflammation- Advances in Understanding and Managing Type 2 Inflammatory Diseases: A Clinical Forum

Program Overview

In this interactive panel discussion, 3 multidisciplinary clinical opinion leaders discuss type 2 Inflammation as an underlying cause of asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyps, with implications for therapeutic choices in patient care.

Credit Expired
CE Credit Expired
Expires: November 22, 2021

Target Audience

The educational design of this activity addresses the needs of physicians who specialize in allergy/immunology, dermatology, otolaryngology, pulmonology, and primary care.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the role of the type 2 inflammatory cascade in the underlying pathophysiology of atopic diseases
  • Identify patients with type 2 inflammatory diseases who are eligible for step-up therapies, including new and emerging biologics

Activity Faculty

Lio

Peter A. Lio, MD, FAAD

Clinical Assistant Professor, Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL

Han

Joseph K. Han, MD

Professor, EVMS
Chief, Division of Rhinology and Endoscopic Sinus-Skull Base Surgery
Chief, Division of Allergy
President Elect, ARS
Chair Elect, AAAAI, RROAC
Eastern Virginia Medical School
Norfolk, VA

anjupeters

Anju T. Peters, MD, MS

Professor, Medicine
Division of Allergy-Immunology
Director, Clinical Research
Northwestern University Feinberg School of Medicine
Chicago, IL

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

© Copyright 2023. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources